pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
Transforming growth factor-beta (TGF-beta) inhibits cell proliferation by inducing a G1-phase cell cycle arrest. Normal progression through G1 is promoted by the activity of the cyclin-dependent protein kinases CDK4 and CDK6 (ref. 2), which are inhibited by the protein p16INK4. We have isolated a new member of the p16INK4 family, p15INK4B. p15 expression is induced approximately 30-fold in human keratinocytes by treatment with TGF-beta, suggesting that p15 may act as an effector of TGF-beta-mediated cell cycle arrest. The gene encoding p15 is located on chromosome 9 adjacent to the p16 gene at a frequent site of chromosomal abnormality in human tumours (9p21).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to p16INK4A, p15INK4B has been shown to an effector of TGF-β meditated cell cycle arrest by inhibiting CDK4/6 (Hannon and Beach, 1994).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Hannon and Beach, 1994
In the citing paper
“Within months of its discovery, the INK4a (CDKN2A) and the genetically linked INK4b gene (CDKN2B) (36) were implicated in a reverse genetic screen to play tumor suppressive roles in familial melanoma (37).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [36]
Citations
Cites
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.
Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., & Fusenig, N. E. (1988) · The Journal of cell biology · doi:10.1083/jcb.106.3.761 · Cited by 4,170
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
The Transforming Growth Factor-beta Family
Massague, J. (1990) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.06.110190.003121 · Cited by 3,015
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
Sherr, C. J. (1993) · Cell · doi:10.1016/0092-8674(93)90636-5 · Cited by 1,960
Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., & Carson, D. A. (1994) · Nature · doi:10.1038/368753a0 · Cited by 1,742
Research works printed but not linked: 7
- Bates, S. et al. Oncogene 9, 71–79 (1994).
- Merlo, A., Gabrielson, E., Askin, F. & Sidransky, D. Cancer Res. 54, 640–642 (1994).
- Cheng, J. Q., Jhanwar, S. C., Lu, Y. Y. & Testa, J. R. Cancer Res. 53, 4761–4763 (1993).
- Petty, E. M. et al. Am. J. hum. Genet. 53, 96–104 (1993).
- Moses, H. L. et al. in Cancer Cells (eds Feramisco, J., Ozanne, B. & Stiles, C.) 3, 65–71 (1985).
- Manning, A. M., Williams, A. C., Gamie, S. M. & Paraskeva, C. Oncogene 6, 1471–1476 (1991).
- Rodeck, U. et al. Cancer Res. 54, 575–581 (1994).
Cited by
Items 901–1,000 of 1,003
Spatial resolution of cellular senescence dynamics in human colorectal liver metastasis
Garbarino, O., Lambroia, L., Basso, G., Marrella, V., Franceschini, B., Soldani, C., Pasqualini, F., Giuliano, D., Costa, G., Peano, C., et al. (2023) · Aging Cell · doi:10.1111/acel.13853 · Cited by 43
“Notably, the cyclin kinase inhibitors p27Kip1 (Lloyd et al., 1999) and p15Ink4b (Hannon & Beach, 1994) were differentially expressed in C_5 and C_8, raising the question of whether the properties of these SMCCs subtypes were fundamentally different.”
BackgroundGenetic Mechanisms Mediating Atherosclerosis Susceptibility at the Chromosome 9p21 Locus
Cunnington, M. S., & Keavney, B. D. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0178-z · Cited by 44
“expression may be induced by transforming growth factor β, which has been implicated in the pathogenesis of atherosclerosis [32, 33].”
BackgroundEdelmann, J., Holzmann, K., Tausch, E., Saunderson, E. A., Jebaraj, B. M. C., Steinbrecher, D., Dolnik, A., Blätte, T. J., Landau, D. A., Saub, J., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.217307 · Cited by 48
Genetic susceptibility to cancer: ICRP Publication 79
Approved by the Commission in May 1997 (1998) · Annals of the ICRP · doi:10.1016/s0146-6435(98)00007-3 · Cited by 69
Fong, L. Y. Y., Nguyêń, V. T., Farber, J. L., Huebner, K., & MAGEE, P. N. (2000) · PubMed · Cited by 47
Wolff, L., Garin, M. T., Koller, R. P., Bies, J., Liao, W., Malumbres, M., Tessarollo, L., Powell, D., & Perella, C. M. (2003) · Oncogene · doi:10.1038/sj.onc.1207092 · Cited by 46
Chromosome 9p21 and Cardiovascular Disease
Samani, N. J., & Schunkert, H. (2008) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.108.832527 · Cited by 43
Effects of Cyclin D1 Overexpression on G1 Progression-Related Events
Imoto, M., Doki, Y., Jiang, W. B., Han, E. K.-H., & Weinstein, I. B. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3713 · Cited by 48
Teofili, L., Martini, M., Mario, A. D., Rutella, S., Urbano, R., Luongo, M., Leone, G. G. M., & Larocca, L. M. (2001) · Blood · doi:10.1182/blood.v98.2.495 · Cited by 42
p16andp15Alterations in Primary Gynecologic Malignancy
Wong, Y. F., Chung, T. K. H., Cheung, T. H., Nobori, T., Yim, S. F., Lai, K. W. H., Yu, A. L.-T., Diccianni, M. B., Li, T. Z., & Chang, A. M. Z. (1997) · Gynecologic Oncology · doi:10.1006/gyno.1997.4669 · Cited by 45
Astrocyte Progression from G1 to S Phase of the Cell Cycle Depends upon Multiple Protein Interaction
Pedram, A., Razandi, M., Ren-ming, H., & Levin, E. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13966 · Cited by 46
Tumor suppressor genes in the TGF–β signaling pathway?
Serra, R. A., & Moses, H. L. (1996) · Nature Medicine · doi:10.1038/nm0496-390 · Cited by 42
Diccianni, M. B., Batova, A., Yu, J., Vu, T., Pullen, J., Amylon, M. D., Pollock, B. H., & Yu, A. L.-T. (1997) · Leukemia Research · doi:10.1016/s0145-2126(97)00007-6 · Cited by 44
Chromosome 9p21 primary open‐angle glaucoma susceptibility locus: a review
Ng, S. K., Casson, R. J., Burdon, K. P., & Craig, J. E. (2014) · Clinical & Experimental Ophthalmology · doi:10.1111/ceo.12234 · Cited by 41
Hamam, D., Abdouh, M., Gao, Z., Arena, V., Arena, M., & Arena, G. O. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0360-9 · Cited by 43
Qin, Y., Liu, J.-Y., Li, B., Sun, Z.-L., & Sun, Z. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i9.1276 · Cited by 41
Molecular mechanisms of the effect of TGF-β1 on U87 human glioblastoma cells
Bryukhovetskiy, I., & Шевченко, В. Е. (2016) · Oncology Letters · doi:10.3892/ol.2016.4756 · Cited by 47
Zhang, D., Tang, H.-Y., Tan, L., & Zhao, D. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110589 · Cited by 43
Adinew, G. M., Taka, E., Mochona, B., Badisa, R. B., MAZZIO, E. A., Elhag, R. I., & Soliman, K. F. A. (2021) · Nutrients · doi:10.3390/nu14010079 · Cited by 47
Gustafsson, A. C., Kupershmidt, I., Edlundh-Rose, E., Greco, G., Serafino, A., Krasnowska, E. K., Lundeberg, T., Bracci‐Laudiero, L., Romano, M.-C., Parasassi, T., et al. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-75 · Cited by 48
p21 WAF1 Mutations and human malignancies
Shiohara, M., Koike, K., Komiyama, A., & Koeffler, H. P. (1997) · Leukemia & Lymphoma · doi:10.3109/10428199709109155 · Cited by 41
Update on genetic events in the pathogenesis of melanoma
Halachmi, S., & Gilchrest, B. A. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200103000-00008 · Cited by 44
Paratore, C., Hagedorn, L., Floris, J., Hari, L., Kleber, M., Suter, U., & Sommer, L. (2002) · The International Journal of Developmental Biology · doi:10.1387/ijdb.11902683 · Cited by 41
“Moreover, it is known that TGFβ is able to interact with members of the CDK inhibitor family that are involved in cell cycle control (Amati et al., 1998; Hannon and Beach, 1994; Polyak et al., 1994).”
BackgroundHommura, F., Dosaka‐Akita, H., Kinoshita, I., Mishina, T., Hiroumi, H., Ogura, S., Katoh, H., & Kawakami, Y. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690750 · Cited by 40
Akiyama, N., Matsuo, Y., Sai, H., Noda, M., & Kizaka‐Kondoh, S. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.3266-3273.2000 · Cited by 43
G1 Cyclins and Control of the Cell Division Cycle in Normal and Transformed Cells
Hamel, P. A., & Hanley-Hyde, J. (1997) · Cancer Investigation · doi:10.3109/07357909709115767 · Cited by 41
Taniguchi, D., Dai, P., Hojo, T., Yamaoka, Y., Kubo, T., & Takamatsu, T. (2009) · Lasers in Surgery and Medicine · doi:10.1002/lsm.20750 · Cited by 43
Mo, X., Luo, Y., Ivanov, A. A., Su, R., Havel, J. J., Li, Z., Khuri, F. R., Du, Y., & Fu, H. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv064 · Cited by 43
“Next, we examined two defined PPIs in different subcellular compartments, i.e. nuclear CDK6/CDKN2B interaction (Hannon and Beach, 1994) and cytoplasmic 14-3-3s dimerization (Fu et al., 2000).”
BackgroundRegulation of the Embryonic Cell Cycle During Mammalian Preimplantation Development
Palmer, N., & Kaldis, P. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.05.001 · Cited by 41
TGF-β2 inhibits AKT activation and FGF-2-induced corneal endothelial cell proliferation
Lu, J., Lu, Z., Reinach, P. S., Zhang, J., Dai, W. H., Luo, L., & Xu, M. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.08.004 · Cited by 40
Mazars, P., Barboule, N., Baldin, V., Vidal, S., Ducommun, B., & Valette, A. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00247-7 · Cited by 41
Yoo, Y. D., Choi, J.-Y., Lee, S., Kim, J. S., Min, B.-R., Lee, Y. I., & Kang, Y. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991112)83:4<512::aid-ijc13>3.0.co;2-z · Cited by 49
“Cyclin D can associate with kinases Cdk 4 and Cdk 6, and Rb is usually used as a substrate for their kinase assay (Hannon and Beach, 1994).”
BackgroundEerola, A., Törmänen, U., Rainio, P., Sormunen, R. T., Bloigu, R., Vähäkangas, K., Lehto, V., Soini, Y., & Pääkkö, P. K. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199702)181:2<172::aid-path715>3.0.co;2-2 · Cited by 56
Tessema, M., Lehmann, U., & Kreipe, H. H. (2004) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-003-0971-3 · Cited by 66
Schneider, G., Oswald, F., Wahl, C., Greten, F. R., Adler, G., & Schmid, R. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204787200 · Cited by 40
p16INK4A as a human tumor suppressor
Shapiro, G. I., & Rollins, B. J. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(95)00011-4 · Cited by 44
Hu, X., & Zuckerman, K. S. (2001) · Stem Cells and Development · doi:10.1089/152581601750098255 · Cited by 41
Vieira, K. B. L., Goldstein, D. J., & Villa, L. L. (1996) · PubMed · Cited by 40
Why are there so many CDK inhibitors?
Xiong, Y. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00012-1 · Cited by 46
Nerve Growth Factor-induced Growth Arrest and Induction of p21 in NIH-3T3 Cells Expressing TrkA
Decker, S. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.30841 · Cited by 44
Hala, M., Hartmann, B. L., Böck, G., Geley, S., & Kofler, R. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19961127)68:5<663::aid-ijc17>3.0.co;2-2 · Cited by 66
Proliferation of Intimal Smooth Muscle Cells
Olson, N. E., Kozlowski, J., & Reidy, M. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11270 · Cited by 45
Chironna, M., Calabrò, M. L., Quarto, M., Germinario, C. A., Fiore, J. R., Favero, A., Potenza, D., Chieco‐Bianchi, L., & Barbuti, S. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960315)65:6<778::aid-ijc12>3.0.co;2-0 · Cited by 7
Differential regulation of p27 and cyclin D1 by TGF-β and EGF in C3H 10T1/2 mouse fibroblasts
Ravitz, M. J., Yan, S., Dolce, C., Kinniburgh, A. J., & Wenner, C. E. (1996) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199609)168:3<510::aid-jcp3>3.0.co;2-s · Cited by 40
Gibbs, Z. A., Reza, L. C., Cheng, C.-C., Westcott, J. M., McGlynn, K., & Whitehurst, A. W. (2020) · eLife · doi:10.7554/elife.57679 · Cited by 41
“For example, TGFβ is well known to facilitate growth inhibition in breast epithelia and most other somatic tissues, primarily through transcriptional activation of cyclin-dependent kinase inhibitors that result in cell cycle arrest (Hannon and Beach 1994; Polyak et al. 1994; Morikawa et al. 2016).”
BackgroundCell biology of Smad2/3 linker region phosphorylation in vascular smooth muscle
Babaahmadi‐Rezaei, H., Kamato, D., Ansari, G., Osman, N., & Little, P. J. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05592.x · Cited by 40
Bantubungi, K., Hannou, S.-A., Caron-Houde, S., Vallez, E., Baron, M., Lucas, A., Bouchaert, E., Paumelle, R., Tailleux, A., & Staels, B. (2014) · Diabetes · doi:10.2337/db13-1921 · Cited by 39
MiR-181a-5p regulates 3T3-L1 cell adipogenesis by targeting Smad7 and Tcf7l2
Ouyang, D., Xu, L., Zhang, L., Guo, D., Tan, X., Yu, X., Qi, J., Ye, Y., Liu, Q., Ma, Y., et al. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmw100 · Cited by 42
Dyck, H. G., Hamilton, T. C., Godwin, A. K., Lynch, H. T., Maines-Bandiera, S., & Auersperg, N. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19961220)69:6<429::aid-ijc1>3.0.co;2-6 · Cited by 92
TGF-βbgr-activating kinase-1 inhibits cell cycle and expression of cyclin D1 and A in LLC-PK1 cells
Terada, Y., Nakashima, O., Inoshita, S., Kuwahara, M., Sasaki, S., & Marumo, F. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00665.x · Cited by 40
Expression of G1-Phase Cell Cycle Genes during Hematopoietic Lineage
Ragione, F. D., Borriello, A., Mastropietro, S., Pietra, V. D., Monno, F., Gabutti, V., Locatelli, F., Bonsi, L., Bagnara, G. P., & Iolascon, A. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.5938 · Cited by 43
Driscoll, B., Tang, A., Hu, Y.-H., Yan, C. L., Fu, Y., Luo, Y., Wu, K., Shumin, W., Shi, X.-H., Barsky, L. W., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9463 · Cited by 40
Engineered in vitro tumor models for cell-based immunotherapy
Ando, Y., Mariano, C. F., & Shen, K. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.076 · Cited by 39
Feng, J., Kim, S., Liu, W., Kim, J. W., Zhang, Z., Zhu, Y., Berens, M., Sun, J., & Xu, J. (2012) · Cancer · doi:10.1002/cncr.26250 · Cited by 38
Discovering How Heme Controls Genome Function Through Heme-omics
Liao, R., Zheng, Y., Liu, X., Zhang, Y., Seim, G. L., Tanimura, N., Wilson, G. M., Hematti, P., Coon, J. J., Fan, J., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107832 · Cited by 35
“Cdkn2b (p15Ink4b) belongs to a CDK4/6 inhibitor family (p15, p16, p18, and p19) (Hannon and Beach, 1994).”
BackgroundEdward, A. M. I. (2005) · Frontiers in bioscience · doi:10.2741/1516 · Cited by 45
Liu, X. P., Tsushimi, K., Tsushimi, M., Kawauchi, S., Oga, A., Furuya, T., & Sasaki, K. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00589-4 · Cited by 41
Tsamandas, A. C., Kardamakis, D. M., Ravazoula, P., Zolota, V., Salakou, S., Tepetes, K., Kalogeropoulou, C., Tsota, I., Kourelis, T., Makatsoris, T., et al. (2004) · Strahlentherapie und Onkologie · doi:10.1007/s00066-004-1149-x · Cited by 42
Karatsaidis, A., Schreurs, O., Helgeland, K., Schenck, K., & Axéll, T. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12633.x · Cited by 37
“TGF-b1 inhibits epithelial cell growth through transcriptional repression of the growth promoting gene c-myc (Pietenpol et al, 1990), and upregulates the cyclin-dependent kinase inhibitors p15 and p21 (Hannon and Beach, 1994; Datto et al, 1995).”
BackgroundDahler, A. L., Cavanagh, L. L., & Saunders, N. A. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01243.x · Cited by 42
Regulation of cyclin dependent kinase inhibitor proteins during neonatal cerebella development
Watanabe, G., Pena, P., Shambaugh, G. E., Haines, G. K., & Pestell, R. G. (1998) · Developmental Brain Research · doi:10.1016/s0165-3806(98)00032-7 · Cited by 40
Association of Stat3-Dependent Transcriptional Activation of p19INK4Dwith IL-6-Induced Growth Arrest
Narimatsu, M., Nakajima, K., Ichiba, M., & Hirano, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7387 · Cited by 41
Intestinal cell cycle regulation
Ko, T. C., Bresnahan, W. A., & Thompson, E. A. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5371-7_4 · Cited by 43
Gong, J., Ko, T. C., & Brattain, M. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1662 · Cited by 38
Recent Insights into the Functions of the Retinoblastoma Susceptibility Gene Product
Kaelin, W. G. (1997) · Cancer Investigation · doi:10.3109/07357909709039722 · Cited by 47
Hypoplasia of endocrine and exocrine pancreas in homozygous transgenic TGF-β1
Moritani, M., Yamasaki, S., Kagami, M., Suzuki, T., Yamaoka, T., Sano, T., Hata, J.-I., & Itakura, M. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.08.007 · Cited by 37
“…(Ewen and Slus 993) or suppressed transcription (Geng and Weinberg, 199 lingerland et al., 1994), and increased inhibition of Cdk2 dk4 by p15INK4b (Hannon and Beach, 1994; Sandhu et 997) or p21kip/sip (Polyak et al., 1994; Reynisdottir et a 995; Reynisdottir and Massague, 1997). p15INK4b…”
BackgroundKuang, C., & Chen, Y. (2003) · Oncogene · doi:10.1038/sj.onc.1207219 · Cited by 37
Zinc Finger Protein 451 Is a Novel Smad Corepressor in Transforming Growth Factor-β Signaling
Feng, Y.-L., Wu, H., Xu, Y., Zhang, Z., Liu, T., Lin, X., & Feng, X. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.526905 · Cited by 40
Huang, L., Yu, D., Wu, C. H., Zhai, K., Jiang, G., Cao, G., Wang, C., Liu, Y., Sun, M., Li, Z., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr228 · Cited by 36
Thakur, N., Kupani, M., Mannan, R., Pruthi, A., & Mehrotra, S. (2021) · BMC Medical Genomics · doi:10.1186/s12920-020-00855-1 · Cited by 37
Baker, B. A., Pine, P. S., Chatterjee, K., Kumar, G., Lin, N. J., McDaniel, J., Salit, M., & Simon, C. G. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.075 · Cited by 36
“The cyclin-dependent kinase inhibitor CDKN2B (also known as p15INK4b) acts as an effector of TGF-bmediated cell-cycle arrest, a potential mechanism by which differentiation is enabled [36].”
BackgroundIshiguro, A., Takahata, T., Saito, M., Yoshiya, G., Tamura, Y., Sasaki, M., & Munakata, A. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04137.x · Cited by 37
Role of p12CDK2-AP1 in Transforming Growth Factor-β1-Mediated Growth Suppression
Hu, M. G., Hu, G., Kim, Y. D., Tsuji, T., McBride, J., Hinds, P. W., & Wong, D. T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2284 · Cited by 42
Wall, S. J., Zhong, Z.-D., & DeClerck, Y. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702697200 · Cited by 37
Opposing actions of TGFβ and MAP kinase signaling in undifferentiated hen granulosa cells
Woods, D. C., Haugen, M. J., & Johnson, A. L. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.107 · Cited by 39
Dao, M. A., Hwa, J., & Nolta, J. A. (2002) · Blood · doi:10.1182/blood.v99.2.499 · Cited by 37
Lucas, P. J., McNeil, N. E., Hilgenfeld, E., Choudhury, B., Kim, S. J., Eckhaus, M., Ried, T., & Gress, R. E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0896 · Cited by 41
Schiemann, S., Schwirzke, M., Brünner, N., & Weidle, U. H. (1998) · Clinical & Experimental Metastasis · doi:10.1023/a:1021941203905 · Cited by 37
Moses, M. A., Marikovsky, M., Harper, J. W., Vogt, P., Eriksson, E., Klagsbrun, M., & Langer, R. (1996) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19960301)60:3<379::aid-jcb9>3.0.co;2-t · Cited by 132
Becker, E. B. E., & Bonni, A. (2005) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2005.02.006 · Cited by 42
Preisler, H. D., Li, Y., Chen, H., Fisher, L., Nayini, J., Raza, A., Creech, S., & Venugopal, P. (2001) · Leukemia · doi:10.1038/sj.leu.2402211 · Cited by 37
E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation
Nip, J., Strom, D. K., Eischen, C. M., Cleveland, J. L., Zambetti, G. P., & Hiebert, S. W. (2001) · Oncogene · doi:10.1038/sj.onc.1204171 · Cited by 43
Peeper, D. S., & Bernards, R. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00319-0 · Cited by 36
Transforming growth factor ? and mouse development
Mummery, C. L. (2001) · Microscopy Research and Technique · doi:10.1002/1097-0029(20010215)52:4<411::aid-jemt1026>3.0.co;2-8 · Cited by 37
Beatson, R., Sproviero, D., Maher, J. F., Wilkie, S., Taylor‐Papadimitriou, J., & Burchell, J. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23217 · Cited by 36
Gao, S., & Jakobs, T. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.11.026 · Cited by 36
Single Nucleotide Polymorphism in SMAD7 and CHI3L1 and Colorectal Cancer Risk
El-Fattah, A. A. A., Sadik, N. A. H., Shaker, O. G., & Kamal, A. M. (2018) · Mediators of Inflammation · doi:10.1155/2018/9853192 · Cited by 42
Baughn, L. B., Liberto, M. D., Niesvizky, R., Cho, H. J., Jayabalan, D. S., Lane, J. M., Liu, F., & Chen‐Kiang, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0713726 · Cited by 42
Disruption of TGFβ Signaling Pathways in Human Pancreatic Cancer Cells
Simeone, D. M., Pham, T. M., & Logsdon, C. D. (2000) · Annals of Surgery · doi:10.1097/00000658-200007000-00011 · Cited by 39
Rorke, E. A., Zhang, D., Choo, C. K., Eckert, R. L., & Jacobberger, J. W. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4953 · Cited by 39
Nargi‐Aizenman, J. L., Ratan, R. R., & Griffin, D. E. (1999) · Neoplasia · doi:10.1038/sj.neo.7900068 · Cited by 37
Yamasaki, K., Toriu, N., Hanakawa, Y., Shirakata, Y., Sayama, K., Takayanagi, A., Ohtsubo, M., Gamou, S., Shimizu, N., Fujii, M., et al. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12239.x · Cited by 38
Kim, J. W., Namkoong, S. E., Ryu, S. W., Kim, H. S., Shin, J. W., Lee, J. M., Kim, D. H., & Kim, I. K. (1998) · Gynecologic Oncology · doi:10.1006/gyno.1998.5041 · Cited by 36
Nerve Growth Factor in Pituitary Development and Pituitary Tumors
Missale, C., & Spano, P. (1998) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1998.0165 · Cited by 38
Zhou, W. J., Park, I. I., Pins, M., Kozlowski, J. M., Jovanovic, B., Zhang, J., Lee, C., & Ilio, K. Y. (2003) · Endocrinology · doi:10.1210/en.2003-0554 · Cited by 44
CDKN2 in HPV‐positive and HPV‐negative cervical‐carcinoma cell lines
Kelley, M. J., Otterson, G. A., Kaye, F. J., Popescu, N. C., Johnson, B. E., & DiPaolo, J. A. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630214 · Cited by 43
Role of epigenetic changes in hematological malignancies
Lehmann, U., Brakensiek, K., & Kreipe, H. H. (2004) · Annals of Hematology · doi:10.1007/s00277-003-0798-7 · Cited by 36
The regulation of cyclin-dependent kinase inhibitors (CKIs)
Peter, M. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5371-7_8 · Cited by 42
Coskun, V., Venkatraman, G., Yang, H., Rao, M. S., & Luskin, M. B. (2001) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(00)00092-7 · Cited by 37
“…TGF-b proteins, a superfamily to which the BMPs belong, have direct effects on the CIP/KIP as well as INK4 family of proteins in vitro, leading to cell cycle arrest and/or apoptosis (Hannon and Beach, 1994; Florenes et al., 1996; Sandhu et al., 1997; Kamesaki et al., 1998; Suzuki et al., 1999).”
Background(+)-Terrein inhibits human hepatoma Bel-7402 proliferation through cell cycle arrest
Zhang, F., Mijiti, M., DING, W., Song, J., Yin, Y., Sun, W. Y., & Li, Z. (2015) · Oncology Reports · doi:10.3892/or.2015.3719 · Cited by 35
Metadata
- Authors
- Hannon, G. J., & Beach, D.
- Affiliations
- Howard Hughes Medical Institute (US)
- ORCID
- Hannon, Gregory J.
- Venue
- Nature
- Published
- 1994-09
- Volume
- 371
- Issue
- 6494
- Pages
- 257-261
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2003907692
- Cited by
- 1,950
- References
- 29
- Citations by year
- 2026: 14 · 2025: 11 · 2024: 26 · 2023: 26 · 2022: 22 · 2021: 30 · 2020: 18 · 2019: 42 · 2018: 29 · 2017: 24 · 2016: 37 · 2015: 48 · 2014: 37 · 2013: 44 · 2012: 54
- FWCI
- 51.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- CDKN2B, p16INK4, TGF-beta, cell cycle arrest, G1 phase, CDK4, CDK6, cyclin-dependent kinases, keratinocytes, 9p21, tumor suppressor, chromosome 9
- MeSH terms
- Amino Acid Sequence, Base Sequence, Carrier Proteins, Cell Cycle, Cell Line, Cloning, Molecular, Humans, Molecular Sequence Data, Proto-Oncogene Proteins, RNA, Messenger, Keratinocytes, Gene Expression, Transforming Growth Factor beta, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Cyclin-Dependent Kinases, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Proteins, Cyclin-Dependent Kinase Inhibitor p15, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.